Menopause Hormone Therapy (HRT) in Joplin, MO

Bioidentical hormones in Joplin: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Estradiol, the main estrogen the ovaries make before menopause, and micronized progesterone both fit that description. Neither has to be compounded: FDA-approved estradiol comes as pills, patches, gels, sprays, vaginal creams and rings, and progesterone as capsules.

Many products sold as "bioidentical hormones" or "BHRT" are compounded instead: mixed by a pharmacy for one prescription, often as a custom cream or a pellet. None of these is FDA-approved, and the FDA has not reviewed them for safety, effectiveness or quality before sale. In the FDA's words, it has no evidence that compounded "bioidentical hormones" are safe and effective. When the National Academies reviewed them in 2020, the evidence was mostly low quality, such as anecdotes and patient reports.

Through VevaMD, a physician licensed in Missouri decides whether hormone therapy fits you and, if so, the form: an estradiol pill, patch, cream or vaginal cream, with progesterone if you have a uterus. Pellets are not part of it. Since the pharmacy that fills these prescriptions also compounds, ask whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

For its size, Joplin is well supplied with OB-GYNs: the NPI registry lists 22, or 42.1 per 100,000 residents, against 17.8 for the US and above Missouri's 18.5. Set against the city's 5,933 women aged 45 to 64, that is one OB-GYN for roughly every 270.

Supply stays thin beyond the city line: 22 OB-GYNs within 10 miles and 36 within 25, only 14.2 per 100,000 of the 253,841 people who live in that radius, under the US 17.8. VevaMD is an online option alongside them: a physician licensed in Missouri reviews your intake from Joplin without an office visit, and an OB-GYN you already see stays your doctor.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG recommends FDA-approved menopause hormone therapy over compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11